The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 261.50
Bid: 261.60
Ask: 261.80
Change: 0.80 (0.31%)
Spread: 0.20 (0.076%)
Open: 262.20
High: 262.80
Low: 259.10
Prev. Close: 260.70
MKS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Christmas 2023/2024 Trading

11 Jan 2024 07:00

RNS Number : 3201Z
Marks and Spencer Group PLC
11 January 2024
 

 

MARKS AND SPENCER GROUP PLC

CHRISTMAS TRADING - 13 WEEKS TO 30 DECEMBER 2023

M&S SUSTAINS STRONG SALES MOMENTUM

 

 

 

Third quarter sales growth, constant currency

£m

Total Sales %

Like-for-Like %

Food

2,332

10.5

9.9

Clothing & Home

1,236

4.8

4.8

Total UK

3,568

8.5

8.1

International

288

(6.4)

 

Group

3,856

7.2

 

Ocado Retail sales are not included in this statement and are reported separately by Ocado Group plc.

Stuart Machin, Chief Executive said: "Our strategy to reshape M&S for growth has enabled sustained sales momentum across Food and Clothing & Home over the Christmas period.?Thank you to our customers for shopping with us and to our colleagues who worked incredibly hard. 

? 

In Food, we led the market on volume growth every month with a c.7% increase across the quarter, and served more customers than ever before. Core categories grew strongly and renewal stores, which cater to larger basket shops, performed particularly well, as more customers looked to us for more of their full shop.

? 

In Clothing & Home, we delivered a good performance with sales growing ahead of the market and less stock going into sale. Womenswear has been the standout, growing volume and value significantly ahead of the market. 

 

Underpinning the strong performance in both businesses is our commitment to trusted value - unbeatable M&S quality at the best possible price. In Food, we inflated below the market, with quality perception increasing further. In Clothing & Home, style perception continued to improve and we maintained our lead on quality and value, delivering an increase in full price sales mix and our highest full price market share for over a decade.

? 

We enter 2024 with a spring in our step, but clear eyed on the near-term challenges. We are determined to deliver our objective of driving 1% growth in market share in both businesses and to up the pace of our transformation: keeping a relentless focus on trusted value; accelerating our store rotation and renewal plans; doubling down on our supply chain programmes to improve availability and lower costs; and resetting our data, digital and technology strategy to unlock benefits in future years. 

? 

Our vision is to be the most trusted retailer, doing the right thing for our customers, with quality products at the heart of everything we do, and we are just at the beginning of what we can achieve. Lots done, lots to do, lots of opportunity ahead."? 

 

Food sales increased 10.5%, with LFL sales up 9.9%. M&S was the top performing grocer in volume growth terms1 over the Christmas period and the quarter, with growth of c.7%, as we served more customers in the period. Supply chain improvements helped to drive better availability year-on-year, although there is more to do. Categories such as meat, poultry, produce, grocery and in-store bakery delivered strong growth, supported by our programme of innovation and quality upgrades. 'Remarksable' value sales grew c.18% as we continue to invest in trusted value.

Clothing & Home sales increased 4.8%, with LFL sales also up 4.8% driven by growth in average selling price, partly a result of reduced promotions year-on-year. Market share increased2, led by the strong performance of womenswear, supported by improved customer perceptions of style, quality and value. Store sales increased 2.0%, with new full line stores performing ahead of plan. Online sales grew 10.9%, with improved carrier service levels compared with last year and strong demand for click and collect. Knitwear, denim, and top of range Autograph lines performed well. Full price sales mix improved and stock into sale reduced 6% year-on-year. With a deeper initial cut in line with our objective of a shorter clearance sale, sell through rates have been encouraging.

International sales were down 6.4%, largely driven by the planned timing of franchise shipments in the Middle East and Asia and more challenging market conditions in India. We are reviewing our priorities, working with our franchise partners, to improve performance.

Outlook. As we enter the new year and FY25, expectations for economic growth remain uncertain, with consumer and geopolitical risks. We also face additional cost increases from higher than anticipated wage and business rates related cost inflation. Nevertheless, the strong Christmas trading performance provides confidence that the results for the year will be consistent with market expectations.

Employee share save scheme. We are very pleased that with improved trading performance and the resultant increase in the share price, over 9,200 colleagues - the majority being customer service assistants - are expected to benefit from the vesting of the 2020 employee share save scheme on 1 February 2024. A colleague saving a typical £150 per month in the scheme will gain over £10,000. To satisfy this, M&S applied to issue 70m new ordinary shares on 14 December 2023.

For further information, please contact:

Investor Relations: Fraser Ramzan: +44 (0) 7554 227 758; Sandeep Dasgupta: +44 (0) 7868 735 381

Corporate Press Office: +44 (0)20 8718 1919

1. Kantar FMCG Purchase Panel; Total grocery 4 and 12 weeks ended 24 December 2023

2. Kantar Fashion Clothing & Footwear 12 weeks ended 10 December 2023

 

- Ends -

Important Notice:

Statements made in this announcement that look forward in time or that express management's beliefs, expectations or estimates regarding future occurrences and prospects are "forward-looking statements" within the meaning of the United States federal securities laws. These forward-looking statements reflect Marks & Spencer's current expectations concerning future events and actual results may differ materially from current expectations or historical results. Any forward-looking statements are subject to various risks and uncertainties, including, but not limited to, failure by Marks & Spencer to predict accurately customer preferences; decline in the demand for products offered by Marks & Spencer; competitive influences; changes in levels of store traffic or consumer spending habits; effectiveness of Marks & Spencer's brand awareness and marketing programmes; general economic conditions including, but not limited to, those related to the Covid-19 pandemic or a downturn in the retail or financial services industries; acts of war or terrorism worldwide; work stoppages, slowdowns or strikes; and changes in financial and equity markets. For further information regarding risks to Marks & Spencer's business, please consult the risk management section of the 2023 Annual Report (pages 56-65).

The forward-looking statements contained in this document speak only as of the date of this announcement, and Marks & Spencer does not undertake to update any forward-looking statement to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDZGMMMGGGDZZ
Date   Source Headline
2nd Apr 20249:00 amRNSTotal Voting Rights
28th Mar 20245:23 pmRNSHolding(s) in Company
28th Mar 20243:07 pmRNSDirector/PDMR Shareholding
26th Mar 20243:07 pmRNSDirector/PDMR Shareholding
7th Mar 20243:16 pmRNSHolding(s) in Company
7th Mar 20248:40 amRNSKatie Bickerstaffe - Planned Leadership Evolution
4th Mar 20243:11 pmRNSDirector/PDMR Shareholding
1st Mar 20249:00 amRNSTotal Voting Rights
28th Feb 20241:43 pmRNSDirector/PDMR Shareholding
16th Feb 20249:00 amRNSDirector Declaration
1st Feb 20249:00 amRNSTotal Voting Rights
30th Jan 20242:53 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
15th Jan 20242:36 pmRNSHolding(s) in Company
11th Jan 20247:00 amRNSChristmas 2023/2024 Trading
10th Jan 20243:28 pmRNSChange To Board Committee Membership
5th Jan 20244:23 pmRNSHolding(s) in Company
2nd Jan 20249:00 amRNSTotal Voting Rights
2nd Jan 20249:00 amRNSBlock listing Interim Review
28th Dec 202311:40 amRNSDirector/PDMR Shareholding
20th Dec 202311:36 amRNSHolding(s) in Company
19th Dec 202310:30 amRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSAdditional Listing
12th Dec 20239:13 amRNSDirector/PDMR Shareholding
1st Dec 20239:00 amRNSTotal Voting Rights
28th Nov 20232:55 pmRNSDirector/PDMR Shareholding
9th Nov 202310:29 amRNSDirector/PDMR Shareholding
8th Nov 20237:00 amRNSHalf-year Report
1st Nov 20239:00 amRNSTotal Voting Rights
30th Oct 20235:01 pmRNSDirector/PDMR Shareholding
2nd Oct 20239:00 amRNSTotal Voting Rights
28th Sep 20233:18 pmRNSDirector/PDMR Shareholding
20th Sep 20233:33 pmRNSHolding(s) in Company
20th Sep 20239:00 amRNSDirector/PDMR Shareholding
19th Sep 20239:01 amRNSDirector/PDMR Shareholding
1st Sep 20239:00 amRNSTotal Voting Rights
30th Aug 202310:34 amRNSDirector/PDMR Shareholding
16th Aug 20233:00 pmRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSTrading Update and Outlook for the Year
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 202311:33 amRNSDirector/PDMR Shareholding
7th Jul 20234:18 pmRNSDirector/PDMR Shareholding
4th Jul 20232:13 pmRNSResult of AGM
3rd Jul 20239:00 amRNSTotal Voting Rights
3rd Jul 20239:00 amRNSBlock listing Interim Review
28th Jun 20232:01 pmRNSDirector/PDMR Shareholding
19th Jun 20234:41 pmRNSDirector/PDMR Shareholding
8th Jun 20235:01 pmRNSHolding(s) in Company
7th Jun 20232:56 pmRNSHolding(s) in Company
6th Jun 202310:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.